期刊
JOURNAL OF NEUROCHEMISTRY
卷 133, 期 4, 页码 572-581出版社
WILEY-BLACKWELL
DOI: 10.1111/jnc.13079
关键词
Alzheimer's disease; brain metabolism; fructose; Glut5; glyceraldehyde; ketohexokinase
资金
- Oslo University Hospital, Oslo, Norway
- Norwegian Health Association
Fructose reacts spontaneously with proteins in the brain to form advanced glycation end products (AGE) that may elicit neuroinflammation and cause brain pathology, including Alzheimer's disease. We investigated whether fructose is eliminated by oxidative metabolism in neocortex. Injection of [C-14] fructose or its AGE-prone metabolite [C-14] glyceraldehyde into rat neocortex in vivo led to formation of C-14-labeled alanine, glutamate, aspartate, GABA, and glutamine. In isolated neocortical nerve terminals, [C-14]fructose-labeled glutamate, GABA, and aspartate, indicating uptake of fructose into nerve terminals and oxidative fructose metabolism in these structures. This was supported by high expression of hexokinase 1, which channels fructose into glycolysis, and whose activity was similar with fructose or glucose as substrates. By contrast, the fructose-specific ketohexokinase was weakly expressed. The fructose transporter Glut5 was expressed at only 4% of the level of neuronal glucose transporter Glut3, suggesting transport across plasma membranes of brain cells as the limiting factor in removal of extracellular fructose. The genes encoding aldose reductase and sorbitol dehydrogenase, enzymes of the polyol pathway that forms glucose from fructose, were expressed in rat neocortex. These results point to fructose being transported into neocortical cells, including nerve terminals, and that it is metabolized and thereby detoxified primarily through hexokinase activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据